Georgia vs Myanmar: Access to anti-retroviral drugs, male
Georgia
72.0%
in 2024
Myanmar
73.0%
in 2024
Georgia rank
65th
Myanmar rank
62nd
Access to anti-retroviral drugs, male over time
- Georgia
- Myanmar
How they compare
Myanmar currently reports 73.0% against 72.0% in Georgia, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Georgia ranks 65th and Myanmar ranks 62nd of 141 countries.
Across the 3 decades both report, Georgia averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Georgia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.7% | 2.2% | 10.5% | Georgia |
| 2010s | 53.3% | 34.8% | 18.5% | Georgia |
| 2020s | 69.4% | 71.2% | 1.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Georgia or Myanmar?
- Myanmar, at 73.0% against 72.0% in Georgia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Georgia and Myanmar?
- 1.0%, with Myanmar ahead.
- How many years of comparable data are there for Georgia and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Georgia and Myanmar rank globally for access to anti-retroviral drugs, male?
- Georgia ranks 65th and Myanmar ranks 62nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.